Clinical Trials Directory

Trials / Completed

CompletedNCT02886637

Effects of Immune Function on Prognositic Outcome in Critical Ill Patients With Acinetobacter Baumannii Infection

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Southeast University, China · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of the present study is to evaluate the effects of immune function on prognositic outcome in critical ill patients with Acinetobacter baumannii infection.

Detailed description

This is a single-center, observational study. Patients with Acinetobacter baumannii infection in the intensive care unit of Zhongda Hospital were enrolled. We recorded the data of age, ICU admission diagnosis, underlying diseases, APACHE II score and infection site. Body temperature, heart rate, white blood cell counts, procalcitonin, C-reactive protein, SOFA score and the level of CD4+, CD8+, Th1, Th2 and HLA-DR in the blood measured by flow cytometry on the D1, D3 and D7 were also recorded.We can get the results of the change of immune function of critical ill patients after Acinetobacter baumannii infection. After compare the patients who die of survive at 28 day after infection, we can get the results of the relationship between the immune function and the outcome. We also can calculate the effect immune function on prognositic mortality in patients with Acinetobacter baumannii infection.

Conditions

Interventions

TypeNameDescription
OTHERNone intervention

Timeline

Start date
2015-07-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2016-09-01
Last updated
2016-09-01

Source: ClinicalTrials.gov record NCT02886637. Inclusion in this directory is not an endorsement.